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Abstract.  A  common feature shared by myosin- 
binding proteins from a wide variety of species is the 
presence of a variable number of related internal mo- 
tifs homologous to either the Ig C2 or the fibronectin 
(Fn) type III repeats.  Despite interest in the potential 
function of these motifs, no group has clearly demon- 
strated a  function for these sequences in muscle, ei- 
ther intra-  or extracellularly.  We have completed the 
nucleotide sequence of the fast type isoform of 
MyBP-C (C protein) from chicken skeletal muscle.  The 
deduced amino acid sequence reveals seven Ig C2 sets 
and three Fn type 111 motifs in MyBP-C. a,-chymo- 
tryptic digestion of purified MyBP-C gives rise to four 
peptides.  NH2-terminal sequencing of these peptides 
allowed us to map the position of each along the pri- 
mary structure of the protein.  The 28-kD peptide con- 
tains the NH2-terminal sequence of MyBP-C, including 
the first C2 repeat.  It is followed by two internal pep- 
tides, one of 5 kD containing  exclusively spacer se- 
quences between the first and second C2 motifs, and a 
95-kD fragment containing  five C2 domains and three 
fibronectin type HI motifs. The C-terminal  sequence of 
MyBP-C is present in a 14-kD peptide which contains 
only the last C2 repeat.  We examined the binding 
properties of these fragments to reconstituted (syn- 
thetic) myosin filaments.  Only the COOH-terminal 14- 
kD peptide is capable of binding myosin with high 
affinity.  The NH2-terminal 28-kD fragment has no 
myosin-binding,  while the long internal  100-kD pep- 
tide shows very weak binding to myosin. We have ex- 
pressed and purified the 14-kD peptide in Escherichia 
coli.  The recombinant protein exhibits saturable bind- 
ing to myosin with an affinity comparable to that of 
the 14-kD fragment obtained by proteolytic digestion 
(1/2 max binding at =0.5 #M).  These results indicate 
that the binding to myosin filaments is mainly re- 
stricted to the last  102 amino acids of MyBP-C. The 
remainder of the molecule (1,032 amino acids) could 
interact with titin,  MyBP-H (H protein) or thin fila- 
ment components. 
A comparison of the highly conserved Ig C2 do- 
mains present at the COOH-terminus of five MyBPs 
thus far sequenced (human  slow and fast MyBP-C, hu- 
man and chicken MyBP-H, and chicken MyBP-C) was 
used to identify residues unique to these myosin- 
binding Ig C2 repeats. 
T 
HICK filaments  from striated  muscle contain myosin 
and a unique set of associated proteins (Offer et al., 
1973;  Craig and  Offer,  1976;  Reinach  et al.,  1982, 
1983; Starr and Offer, 1983, Bahler et al.,  1985a,b; Hart- 
zell and Glass, 1984; Cooper and Trinick,  1984; Yamamoto 
and Moos,  1983;  Price,  1987).  Myosin-binding  protein-C 
(MyBP-C),I C protein, was originally  identified as an abun- 
dant  140-kD  contaminant  present in  myosin  preparations 
(Offer et al., 1973). MyBP-C is found in the inner two-thirds 
of the cross-bridge beating region of the A band, with a 43- 
nm axial  spacing  (Craig  and Offer,  1976;  Bennett,  1986; 
Dennis et al.,  1984; Bahler et al.,  1985b).  It was first esti- 
1.  Abbreviations  used in  this paper:  FN,  fibronoctin;  MyBPC,  myosin- 
binding protein-C; PM, poctoralis muscle. 
mated that two molecules of MyBP-C are present at each 43- 
nm repeat (Offer et al., 1973) although later studies by Mori- 
moto and Harrington (1973, 1974) indicate that the value is 
closer to three per stripe.  The interactions  of MyBP-C with 
myosin filaments are complex:  (a) there are different classes 
of myosin binding  sites of different affinities (Davis,  1988); 
(b) MyBP-C lowers the critical concentration for myosin po- 
lymerization  (Davis,  1988); and (c) MyBP-C binds to titin, 
another myofibriUar protein known to bind myosin (Fiirst et 
al., 1992). Variant isoforms of MyBP-C are present in differ- 
ent muscles (Reinach  et al.,  1982) and are expressed in a 
regulated  program  during  development  (Obinata  et  al., 
1984). In some muscles more than one isoform is present in 
a single sarcomere (Reinach et al., 1983) or even in a single 
43-nm repeat along the thick filament (Dennis et al., 1984). 
MyBP-C has a rod-shaped appearance with a "hinge" region 
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scope (Swan and Fischman,  1986; Hartzell and Sale, 1986). 
A partial eDNA for the fast-type isoform of MyBP-C from 
chicken pectoralis muscle has been isolated  (Einheber and 
Fischman,  1990). Its deduced amino acid sequence revealed 
the presence of 9 internal  domains,  6 homologous to Ig C2 
motifs  and three to the fibronectin  (Fn)  type HI repeats. 
MyBP-C is therefore a member of the Ig superfamily  (Cun- 
ningham et al., 1987; Williams,  1987; Williams and Barclay, 
1988). The Ig C2 and Fn Ill repeats are conserved in human 
MyBP-C  (Fiirst  et  al.,  1992)  and  often  found  in  other 
myosin-associated  proteins (Ayme-Southgate,  1991; Benian 
et al.,  1989; Olson et al.,  1990; Labeit et al.,  1990; Price 
et al.,  1991; Noguchi et al.,  1992; Kobayashi et al.,  1992; 
Vaughan et al.,  1993a,b). Since the location of the myosin- 
binding site(s) in MyBP-C has not been established, the role 
of C2 or fibroneetin  motifs in myosin binding  remains  un- 
certain. 
Here we describe the ot-chymotrypsin  proteolytic frag- 
ments of MyBP-C, map their position along the MyBP-C se- 
quence,  which we have  now completed,  demonstrate the 
presence of a  seventh  IgC~ domain  and determine  which 
fragments  are capable of binding  to synthetic  myosin illa- 
ments.  In addition,  we now report the bacterial expression 
of the myosin-binding domain and demonstrate its functional 
properties in a myosin filament binding  assay. 
Materials and Methods 
Construction  and Screening of a Primer 
Extension Library 
Using the oligonucleotide 5'-GGATGAACGCTTCGCTCTTT-3',  derived 
from the partial sequence of MyBP-C (Einheber and Fischman, 1990) and 
mRNA from 1-wk posthatch chicken pectoralis muscle (PM), a primer ex- 
tension eDNA library was prepared. First and  second strand synthesis, 
methylation, polishing of free ends, and ligation of EcoR1 linkers were per- 
formed as described (Reinach and Fischman,  1985).  The eDNA was di- 
gested with EcoRI and size-fractionated by column chromatography using 
Sepharose 4B. cDNAs exceeding 500bp were ligated into ~ZAP and pack- 
aged. The library was screened by plaque hybridization (Sambrook et al., 
1990) using a 300-bp fragment derived from the partial eDNA for MyBP-C 
(bases 500-800)  (Einheber et al.,  1990). 
DNA Sequencing 
The cDNAs were subeloned into MI3 mpl8 and mpl9 for dideoxy sequenc- 
ing (Sanger et al.,  1977).  Both strands were sequenced. 
Crude Myosin Preparation 
Crude myosin was prepared from chicken skeletal muscle as described 
(Reinach et ai.,  1982). 
Purification of  MyBP-C 
A crude myosin preparation was used to prepare MyBP-C by a combination 
of DEAE-cellulose and hydroxyapatite as described (Reinach et al., 1982) 
or by a method which avoids the degradation of MyBP-C sometimes ob- 
served in the hydroxyapatite columns. In this new procedure, a crude myo- 
sin preparation was mixed with Q-Sepharose fast flow (Pharmacia, Upp- 
saia, Sweden), equilibrated with 0.135 M KH2PO4, 0.015 M K2HPO4 (pH 
7.0),  1 mM DTT, 2 mM EDTA, and 0.5 mM PMSF (Q buffer), and placed 
on a Buchner funnel containing 3 mm paper (Whatman Laboratory Prod- 
ucts, Inc., Clifton, NJ). About 50 ml of preswollen resin was required to 
process 100 mg of crude MyBP-C. MyBP-C did not bind to Q-Sepharose 
under these conditions and  was  collected in  the flow through volume. 
MyBP-C was concentrated with ammonium sulfate (27-42%  saturation) 
and resnspended in Q buffer. After dialysis against the same buffer, the sam- 
ple was cleared at 100,000 g for 2 h and loaded on a Q-Sepharose fast flow 
column equilibrated with Q-buffer (16 x  300-mm run at 2 ml/min). MyBP-C 
and MyBP-H were collected in the flow through (Bahler et al.,  1986a; 
Vanghan et al., 1993a). Bound myosin was eluted with Q buffer containing 
0.3 M KCI, concentrated by addition of ammonium sulfate (20-45 % satura- 
tion) and dialyzed against 0.6 M  KC1, 20 mM Tris-C1  (pH 7.5), 2  mM 
EDTA, and 2 mM DTT. Column-purified myosin was mixed with an equal 
volume of glycerol and stored at  -20°C. 
The crude fraction containing MyBP-C and MyBP-H was loaded on an 
Afligel blue column (16 x  200-ram run at 0.5 ml/min) (Bio-Rad Laborato- 
ries, Richmond, CA), equilibrated with 0.3 M KCI, 20 mM Imidazole-HCl 
(pH 7.0),  1 mM EGTA, 1 mM DTT, 0.5 mM PMSE and 0.5 #g/ml leupep- 
tin. MyBP-C was eluted with a linear gradient (0.3-1.0 M KCI in the same 
buffer). Up to 40 #g of the fraction from the Q-Sepharose column could 
be separated on each run of the Aitigel blue column. Fractions containing 
MyBP-C were transferred to a dialysis bag and immersed in solid polyethyl- 
ene glycol (Mr-20,000).  Concentrated MyBP-C was then dialyzed against 
0.3 M KCI, 20 mM Imidazole-HCl (pH 7.0),  1 mM DTT, 0.5 mM PMSE 
0.5 #g/ml leupeptin, and 50%  glycerol and stored at  -20°C. 
Cleavage of  MyBP-C with a-Chymotrypsin 
Before c~-chymotryptic cleavage of MyBP-C, PMSF was removed by dialy- 
sis or passage over a Sephadex (325 column. MyBP-C (0.5-1  #g/ml) was 
mixed  with  1/500  wt/wt  of a-chymotrypsin  in  0.1  M  KCI,  20  mM 
Imidazole-HC1 (pH 7.0), and incubated at 23°C. The cleavage reaction was 
terminated at selected time points by addition of 1 mM PMSE 
Purification of ~-Chymotryptic Peptides 
To purify the fragments under nondenaturing conditions, products of the 
cleavage reaction were fractionated on a Superose 12 FPLC column (Phar- 
macia; 10  x  300-ram run at 0.3 ml/min) equilibrated with 0.1 M KC1, 20 
mM Imidazole-HCl (pH 7.0),  1 mM DTT,  1 mM EGTA,  and 0.5  mM 
PMSE  Proteolytic fragments were also purified under denaturing condi- 
tions for the determination of NH2-terminal sequences. SDS (0.1%)  and 
DTT (0.1 mM), were added to the digest which was then dialyzed against 
0.12 mM NaC1,  50 mM Tris-HCl, pH 8.0, 0.1% SDS, 0.5 mM DTT,  and 
fractionated by gel filtration on a Sephacryl S-200 column (20 x  850 mm) 
equilibrated with the same buffer. Pooled fractions containing the proteo- 
lytic fragments and intact MyBP-C were dialyzed against water,  lyophi- 
lized, and sequenced using automated Edman degradation. 
Expression and Purification of the 14-kD Fragment 
in E. coli 
Two mutagenic oligonucleotides and the full-length cDNA were used in a 
polymerase chain reaction to generate a DNA fragment encoding the last 
C2 domain of MyBP-C. The first oligonucleotide (5'-TTGAATTCGCTG- 
ACCCTAACCATGGTGCCCTAT-35  creates an NcoI site before methio- 
nine 1027 in the protein sequence (see Fig.  1) and an EcoRI site further 
upstream.  This  methionine is  located three residues before the c,-chy- 
motrypsin cleavage site that generates the  14-kD  fragment. The second 
oligonucleotide:  (Y-TTAAGCIq'CTCTGCGATGGGATCCTCATTG-3~  cre- 
ates a BamHI site just after the stop codon and a HindIII site further down- 
stream. A PCR reaction was carried out for 30 cycles of 63°C (15 s) 72°C 
(20 s) 94°C (90 s) using standard conditions (Perkin Elmer Cetus CT, Eden 
Prairie, MN). The 300-bp fragment was purified from an agarose gel, di- 
gested with EcoRI and HindllI and cloned in pUC19. After sequencing the 
insert was excised with NcoI/BamHI and cloned in NcoI/BamHI cut pET3d 
(Studier et al.,  1990)  to produce the final construct (pET-C2). 
Escherichia  coli  strain  BL-21(DE3),  transfected with pET-C2,  were 
grown to ODto0  =  0.6  in LB media,  induced with 0.4 mM IPTG,  and 
grown for another 3-4 h. Cells were collected by centrifugation (10,000 g), 
resuspended in 50 mM Tris-C1 pH 8.0, 2 mM EDTA. Lysozyme and Triton 
X-100 were added to a final concentration of 100 #g/ml and 0.1%, respec- 
tively. After a 10-rain incubation at room temperature; the lysate was chilled 
on ice and sonicated for 30 s. After centrifugation (15000 g, 15 min) the 
pellet was washed twice with lysis buffer without lysozyme, resuspended 
8 M Urea, 50 mM Tris-C1 (pH 8.0), 1 mM EDTA, and loaded onto a DEAE- 
cellulose column equilibrated in the same buffer.  Material eluting in the 
void volume was collected, diluted to a concentration below 0.5 mg/ml and 
renatured by slow dialysis. Two changes of 50 mM Tris-Cl (pH 7.5), 0.3 M 
NaC1,  2 mM DTT were followed by two changes of 50 mM Tris-Cl (pH 
7.5), 0.15 M NaC1, 2 mM DTT, and 0.5 mM EDTA. At this step the protein 
could be concentrated and stored frozen. Circular dichroism measurements 
of the purified and  renatured  recombinant peptide (0.25  mg/ml  in the 
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trometer in the 200-250-nm UV range. 
Binding of  MyBP-C and MyBP-C Fragments to Myosin 
Myosin stored in glycerol was dialyzed against 0.1  M  KCI, 20 mM Imi- 
dazole-HC1 (pH 7.0), and 1 mM DTT to obtain synthetic filaments. MyBP-C 
or its c~-chymotryptic peptides in the same buffer were mixed with pre- 
formed myosin filaments for 10 min in a final volume of 100 #1. Filaments 
were sedimented in an Airfuge (Beckman Instruments, Palo Alto, CA) at 
22 P.S.I.  for 20 rain and the pellets analyzed with SDS-PAGE. Binding of the 
recombinant 14-kD peptide was performed as described above but in 0.1 or 
0.15 M NaC1; 10 mM Tris-C1 (pH 7.5); 1 mM DTT, 0.5 mM EDTA. Under 
these conditions <1% of the 14-kD fragment was sedimented in the absence 
of myosin filaments and >95 % of the added myosin filaments were sedi- 
mented. Gels were stained with Coomassie blue and proteins quantified by 
densitometry. Calibration was achieved with serial dilutions of known quan- 
tities of the same proteins loaded on the same gels. Scanning of the Coomas- 
sic blue-stained gels was performed in a scanner (GS300; Hoffer, San Fran- 
cisco, CA) with a  GS350 data processing system. 
Results 
Full-length Cloning and Sequencing of  MyBP-C 
Sixty independent eDNA  clones encoding MyBP-C were 
isolated to obtain a eDNA containing the complete coding 
sequence. Of the 60 clones, 59 started at the primer used to 
construct the library. One began 500-bp down-stream, possi- 
bly the result of random priming. Of the 59 clones initiated 
by the specific primer, 58 ended within a region of 17 nucleo- 
tides (5'-GGAGGCGCCGCCCCCAC-3'), rich in G-C. This 
region may have formed stable secondary structures, result- 
ing in premature  termination of the reverse transcription 
reaction. Since these cDNAs lacked an open reading frame 
which would generate the amino acid sequence found in the 
28-kD ot-chymotryptic fragment (see below), it was apparent 
that none of these clones spanned the complete coding se- 
quence of the eDNA. A single clone extended 100 bp beyond 
the G-C rich region, including 25 bp of the 5'-untranslated 
region and a partial sequence found in both the 28-kD chy- 
motryptic fragment and in the 128-kD fragment of MyBP-C 
(Table  19.  The overlapping COOH-terminal and NH2-ter- 
minal eDNA  clones generated a  continuous nucleic acid 
sequence of 3,488  bases,  with an open reading frame of 
1,132 amino acids shown in Fig. 1. The complete eDNA se- 
quence has been deposited in Genbank (accession number 
U00922).  Analysis of the deduced protein sequence indi- 
cates that chicken fast-type MyBP-C eDNA is composed of 
seven Ig C2 motifs and three Fn type l/I repeats (Fig. 1); no 
other recognizable motifs were identified. These domains 
have been numbered I-X, from the NH2- to COOH-termi- 
nus. Six C2 motifs were identified in our initial report (Ein- 
heber and Fischman, 1990) but another C2 motif has been 
identified in the NH2-terminal sequence completed in the 
present study. 
Table L Amino Acid Sequences of C-Protein Fragments 
Fragment  Sequence 
128 kD  PEPSKAA  KK 
28 kD  PEPSKAAPKKEAKKKEEKKEEKKE 
5  kD  LKKREVQVEEKKKKKT_.E 
14 kD  KEVDLXAAPQ 
Note:  The underlined residues do not agree with the eDNA sequence possibly 
due to inaccuracies in the protein sequence determination or allelie variation. 
i  MPEPSKAAPK  KEAKKKEEKK  EEKKEAPPPQ  EHKDEAPDDV  HPPETPDPEG  LFLSKPQNVM 
61  VESGRDVTVS  ARVAGAALPC  APAVKWFKGK  WAELGDKSAR  CRLRHSVDDD  KVHTFELTIT 
< .............................  C2  .......................... 
121  KVAMGDRGDY  RCEVTAKEQK  DSCSFSIDVE  APRSSEGNVL  QAFKRTGEGK  DDTAGELDFS 
...................................  > 
lSl  GLLKKREVQV  EEKKKKKDED  DQFPPEIWEL  LKGVTKKSEY  ERIAFQYGIT  DLRGMLKRLK 
241  KVHVEPKKSE  AFIRKLDPAY  QVDKGNKIKL  VVELSDPDLR  LKWYKNGQLL  KPSTKYVFEN 
<  .......................................... 
301 VGLKRILTIH  KCSLADDAAy  ECRVNDEKCF  TEVFVKEPPV  TWRGLEDQQ  VVVGDRWLE 
...........  C2  ...............................  >  <  ........... 
361 AEVSEEGAQV  MWLKDGVDVT  RDDAFKYRFK  KDGKKHFLII  NEAELSDSAH  ¥KIMTNGGES 
...................................  C2  .......................... 
421  EAELSVEEKQ  LEVLQDMADL  TVKASEQAVF  KCEVSDEKVT  GRWFRNGVEV  KPSKRIHISH 
.................  ><  .............................................. 
481  NGRFHKLVID  DVRPEDEGDY  TFIPDGYALS  LSAKLNFLEI  KVEYVPKQEP  PKIHLDCSGK 
...........  C2  ................................  • 
541  AAENTIVVVA  GNKVRLDVPI  SGEPAPTVTW  KRGDQLFTAT  EGRVHIDSQA  DLSSFVIESA 
<  ............................  C2  .......................... 
601  ERSDEGRYCI  TVTNPVGEDS  ATLHVRVVDV  PDPPQSVRVT  SUGEDWAVLS  WEAPPFDGGM 
..............................  •  <==  ....  ========================= 
661  PITGYLMERK  KKGSMRWMKL  NFEVFPDTTY  ESTKMIEGVF  YEMRVFAVNA  IGVSQPSLNT 
===========  FN  ================  ....  =======  ....  =================== 
721  QPFMPIAPTS  EPTHWLEDV  TDTTATIKWR  PPERIGAGGV  DGYLVEWCRE  GSNEWVAANT 
=======~>  <  .....  ======  .....  ======  FN  =========  ....  ~============ 
781  ELVERCGLTA  RGLPTGERLL  FRVISVNMAG  KSPPATMAQP  VTIREIVERP  KIRLPRHLRQ 
=================================================== 
841  TYIRRVGEQV  NLVIPFQGKR  RPQVTWSREG  GALPAEVQTR  TSDVDSVFFI  RSAARPLSGN 
<  ................................  C2  .......................... 
901  YEMRVRIDNM  EDCATLRLRV  VERPGPPQAV  RVMEVWGSNA  LLQWEPPKDD  GNAEISGYTV 
.......................  •  <==========  ....  =====  ......  =======  .....  == 
961  QKADTRTMEW  FTVLEHSRPT  RCTVSELVMG  NEYRFRVYSE  NVCGTSQEPA  TSHNTARIAK 
1081  ADPKFLSRHG  LGVLSLLIRR  PGPFDGGTYG  CRAVNEMGEA  TTECRLDVRV  PQ 
***********************************  C2  *****************> 
Figure 1. Complete amino-acid sequence of chicken MyBP-C and 
the location of the Ig C2 and Fn type IN repeats. The bold amino 
acid sequences indicate those partial sequences obtained from the 
o~-cbymotryptic  fragments of MyBP-C (Table I). Boundaries of the 
immunoglobulin C2  repeats (<--->),  the  fibronectin type  IIl 
repeats (<===>), and the last C2 repeat (<***>) are marked. 
The complete  cDNA sequence  data has been deposited in the EMBL/ 
GenBank databank under accession number U0092. 
Characterization of  MyBP-C Fragments 
Chicken fast-type MyBP-C, from pectoralis muscle was di- 
gested  with  ~-chymotrypsin,  generating  four  proteolytic 
fragments with relative mobilities of 96, 28,  14, and 5 kD, 
respectively (Fig. 2 a). These four fragments were separated 
by gel filtration (Fig. 2 b) and purity assessed by SDS-PAGE 
(Fig. 2 a). Purified fragments of 28, 14, and 5 kD were par- 
tially sequenced  (Table  I)  and then positioned along the 
predicted sequence established from the eDNA (Fig. 1). We 
then performed a time course study of chymotryptic diges- 
tion to obtain products of partial digestion that could be used 
for mapping the myosin-binding domain within the protein 
(Fig. 3, A and B). Within a minute of initiating the reaction, 
four peptides of 128, 100, 28, and 14 kD were detected. The 
14-kD fragment increased in quantity during the first 5 rain 
and then plateaued. The gradual disappearance of the large 
128-kD fragment paralleled the appearance of 100- and 28- 
kD fragments. After 15 min, three major peptides (100, 28, 
and 14 kD) of approximately equal molar ratios could be de- 
tected. The 100-kD fragment was subsequently cleaved into 
two smaller products of 5 and 95 kD (Fig. 3, a and b). These 
results indicate that the site between the 95- and the 14-kD 
fragments is the first to be cleaved, followed by the 28/5-kD 
site and finally by the 5/95-kD site (Fig. 3, c). The partial 
sequence of the 128-kD fragment (Table I) is identical to the 
partial sequence obtained from the 28-kD  fragment, con- 
firming our assignment of the 28-kD fragment to the NH2- 
terminus of the molecule,  and the  14-kD  peptide  to the 
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(A) SDS-PAGE of MyBP-C fractions recovered during isolation of 
the proteolytic fragments. Lane M, molecular weight markers (94, 
68, 42, 30, 20, and 14 kD); lane A, purified chicken pectoralis mus- 
cle MyBP-C; lane B, purified MyBP-C after digestion with a-chy- 
motrypsin; lanes 12-30, samples of the column fractions with the 
corresponding  fraction numbers.  (B) Elution profile of ot-chymo- 
tryptic fragments fractionated on a Sephacryl S-200 column.  The 
elution position of the different fragments are indicated.  Fraction 
numbers are the same as in A. 
Figure 3.  (A)  SDS-PAGE analysis of the time course of MyBP-C 
cleavage with c~-chymotrypsin.  Lanes 1 to 6 show MyBP-C cleaved 
for 0, 4, 8, 16, 30, and 60 min. (B) The relative amount of each frag- 
ment generated during digestion was determined by densitometry 
of Coomassie blue stained gels the data plotted as a function of 
digestion time.  128-kD fragment (o, ---); 100-kD fragment (o); 
95-kD fragment  (n,  ---); 28-kD fragment (zx); 14-kD fragment 
(,t); 5-kD fragment (., ---). Observe that after 15 min of cleav- 
age, only three peptides (100, 28, and 14 kD) are present (arrow). 
(C) Schematic illustration of MyBP-C showing the internal Ig C2 
(~) and Fn type HI (t2) repeats and their relation to the proteolytic 
fragments. 
amounts and accumulates in inclusion bodies (Fig. 4). After 
purification the protein was renatured from urea in the pres- 
ence of high salt and reducing agents as described for the 
troponin  C  and  troponin  I  (Reinach  and  Karlsson,  1988; 
Quaggio et al.  1993). Up to 50 mg of pure recombinant 14- 
kD fragment could be obtained per liter of bacterial culture. 
COOH-terminus.  The  relative  molecular  masses  of  the 
a-chymotryptic fragments were established by SDS-PAGE. 
The sum of the relative masses of the four peptide came to 
142 kD and matched the relative molecular weight of MyBP-C 
purified from chicken PM. The few mismatches between the 
deduced  amino acid  sequences  and the peptide  sequences 
(Table I) may reflect inaccuracies in the Edman peptide se- 
quencing or aUelic variations. Taken together, these data in- 
dicate  that  the  order  of the  ot-chymotryptic fragments in 
MyBP-C is:  N-28 kD-5 kD-95 kD-14 kD-C. 
The distribution of each fragment along the sequence is in- 
dicated in Fig. 1 and their positions within the domain struc- 
ture of the molecule are shown in Fig. 3 c. Interestingly, all 
cleavage sites are located between domains, the 5-kD frag- 
ment containing only "linker" sequences between domains I 
and II (Fig.  3 c). 
To further characterize the COOH-terminal Ig C2 domain 
of MyBP-C the last 106 residues of the chicken protein were 
expressed  in  E.  coli.  The  fragment is  expressed  in  large 
Figure 4.  SDS-PAGE analysis 
of the  protein  fractions  ob- 
tained during the purification 
of  the  recombinant  14-kD 
fragment.  Total  protein  ex- 
tract  of E.  coli  BL21(DE3) 
containing  the  plasmid  pET- 
C2 before induction (NI) and 
after induction  (I)  show the 
accumulation  of the  recom- 
binant protein  (arrow).  After 
lysis the recombinant protein 
is found only in the pellet (P), 
none of  the protein being pres- 
ent  in  the  supernatant  (S). 
The  final  product  after 
DEAE-ceUulose  chromatog- 
raphy is shown in E  Molecu- 
lar weight markers of 96, 68, 
43,  24,  20,  and  14  kD  are 
shown in M. 
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and  MyBP-C  fragments  to 
synthetic  myosin  filaments. 
Fractions containing different 
combinations  of myosin fila- 
ments, MyBP-C and the frag- 
ments of MyBP-C were sedi- 
merited  in  an  air  fuge.  The 
supernatant and pellet of each 
fraction  was  analyzed  using 
SDS-PAGE. The position  of 
the myosin heavy chain (HC), 
myosin  light  chains  (LC1, 
LC2,  and  LC3),  MyBP-C 
(C),  and  the  100-, 28-,  and 
14-kD fragments  (lOOk, 28k, 
and 14k) are indicated. (A) Su- 
pernatants (lanes 1, 2, and 3) 
and pellets (lanes 4, 5, and 6) 
of mixtures  containing  only 
1.3  I~M  myosin  filaments 
(lanes I and 4) or 1.3/~M myo- 
sin and 1.8/~M intact MyBP-C 
(lanes 2 and 5) or 1.3/~M my- 
osin and 1.8/~M of a total di- 
gest of MyBP-C (lanes 3 and 
6)  are shown. In lane 5  ob- 
serve the precipitation  of in- 
tact MyBP-C. In lane  6 ob- 
serve that the 14-kD fragment 
is sedimented with the myosin 
filaments (*) but only a small 
amount  of the  100-kD  frag- 
ment  cosediments  with  the 
myosin filaments (arrowhead). 
(B) Supernatants (lanes 1, 3, and 5) and pellets (lanes 2, 4, and 6) of mixtures containing 2.2 ~M myosin filaments and 2.2 t~M purified 
100-kD (lanes 1 and 2) or 2.2/~M myosin filaments and 2.2 #M purified 28-kD fragment (lanes 3 and 4) or 2.2/~M myosin and 2.2 
#M purified  14-kD fragment (lanes 5 and 6) are shown. In lane 2 observe that only a small fraction of the 100-kD fragment binds to 
the filaments (arrowhead). In lane 6 note that almost half of the  14-kD fragment co-precipitates  with the myosin filaments. (C and D) 
Binding curves of intact MyBP-C and MyBP-C fragments to myosin filaments were obtained as described under Materials and Methods. 
In C, binding of intact MyBP-C (o), purified  14-kD fragments obtained by proteolytic digestion of MyBP-C (e), and 100-kD fragment 
obtained by proteolytic digestion of MyBP-C (,,) were measured in independent experiments. In these experiments myosin concentration 
was kept at 2.2 ~M. In D, binding of recombinant  14-kD fragment was measured in either 0.1 M NaCI (o) or 0.15 M NaC1 (e). Myosin 
concentration was kept at 1.5/~M and the concentration of 14-kD fragment was increased from zero to 4.4/~M (a threefold molar excess 
over myosin) to demonstrate  saturation. 
Binding of  MyBP-C and MyBP-C Fragments 
to Myosin Filaments 
We next examined the binding of MyBP-C and its o~-chymo- 
tryptic fragments to synthetic myosin filaments using a cen- 
trifugation assay. Fig. 5 A shows the protein composition of 
supernatant and pellet fractions after intact MyBP-C or the 
chymotryptic digests are mixed with myosin filaments for 10 
min at a  1:1 molar ratios and then sedimented. A large frac- 
tion of the MyBP-C cosediments with the myosin filaments. 
Densitometric analysis of the pellet reveal a MyBP-C to my- 
osin ratio of 0.65:1 (Fig. 5 A). The fraction of bound MyBP-C 
is not increased by longer incubations with the myosin illa- 
ments. Using a total o~-chymotryptic digest of MyBP-C, only 
the  14-kD COOH-terminal fragment shows significant co- 
sedimentation  with myosin (Fig.  5  A).  The NH~-terminal 
28-kD peptide,  which also contains a  single Ig C2 repeat, 
had no detectable myosin binding. The large internal 100-kD 
peptide exhibits very low binding to myosin filaments (Fig. 
5 A).  TO confirm the binding of the different fragments to 
myosin and to exclude the possibility that the binding of the 
14-kD  fragment was interfering with the binding of other 
fragments to the filaments, we mixed purified fragments, iso- 
lated under nondenaturing conditions, with the myosin illa- 
ments. The results were identical to those obtained with the 
total digests (Fig. 5 B), excluding the possibility that binding 
of the  14-kD peptide competes for a  common binding site 
with the other fragments. 
Binding curves of intact MyBP-C and the fragments to my- 
osin filaments were obtained at a  myosin concentration of 
2.2 t~M. At 1:1 myosin/MyBP-C (2.2 I~M of intact MyBP-C) 
(Fig. 5 C), a stoichiometry of 0.7 moles of MyBP-C per mole 
of myosin was observed in the pellets. A similar stoichiome- 
try (0.65 moles fragment/mole of myosin) was obtained with 
the 14-kD fragment, at near saturating conditions (Fig. 5 C). 
The binding of the 100-kD fragment to myosin filaments was 
very weak (Fig 5  C). 
Okagaki et al. Myosin-binding  Protein  623 Because of difficulties in obtaining sufficient 14-kD frag- 
ment by proteolytic digestion of native MyBP-C, we used a 
recombinant 14-kD fragment to repeat the binding curves at 
high 14-kD peptide concentrations  (Fig. 5/9).  The results 
were similar to the ones obtained with the proteolytic frag- 
ment/saturation occurring at a 0.6:1 (moles of fragment/mol 
of myosin) with an apparent dissociation constant of ,'o0.5 
#M. These data, showing that saturation occurs at molar ra- 
tios of 0.65 to 0.7 moles of 14-kD COOH-terminal proteo- 
lyric peptide or recombinant  14-kD fragment per mole of 
myosin is  in agreement  with previous  measurements per- 
formed with purified rabbit MyBP-C (Moos et al.,  1975). 
The concentration of MyBP-C and 14-kD peptide necessary 
to obtain half-saturation  also agrees with previous studies 
using purified rabbit  MyBP-C (Moos et al.,  1975; Yama- 
moto and Moos, 1983). To assess the secondary structure of 
the renatured,  recombinant peptide, we performed circular 
dichroism  measurements.  As expected  from the  high  se- 
quence homology of this domain with the Ig C2 domain of 
telokin, the CD analysis demonstrated ~30%/~ sheet, 30% 
turns, and 40% random structure;  no a-helix was detected 
(data not shown). These results suggest that the peptide has 
refolded appropriately. 
The fact that the 14-kD fragment retains most of the myo- 
sin-binding properties found in the intact MyBP-C molecule 
suggests that the major high affinity myosin-binding site of 
MyBP-C is restricted to a single C2 immunoglobulin repeat 
located in the last 102 amino acids of  the MyBP-C molecule. 
Two series of preliminary experiments were conducted to 
test whether the recombinant 14-kD peptide was capable of 
competing with MyBP-C for myosin binding. In both cases 
the results were negative (data not shown). In the first set, 
"crude" myosin, i.e., myosin before ionic exchange chroma- 
tography, at 2.2 #M, was mixed in 0.3 M KC1 with 14-kD 
peptide at varying concentrations (0.1-2.0/~M). (The MyBP-C 
concentration  in the crude myosin preparation  was ,',,1/8th 
the molar concentration of  myosin [~0.3 #M].) After reduc- 
tion of the KCI to 0.1 M, the samples were incubated on ice 
for 15 rain and spun at 22 P.S.I. in the airfuge as described 
for the binding  assay above. The supernatant  and pellets 
were  then examined  by  SDS-PAGE and Coomassie  blue 
staining. In none of  three independent experiments was there 
any release of MyBP-C into the supernatant fractions from 
the myosin filament pellets. The second set of experiments 
was designed to test whether other thick filament-associated 
proteins,  e.g., MyBP-H and titin,  which were also present 
in the crude myosin preparations,  could have affected the 
binding of MyBP-C to the myosin filaments. A separate set 
of  experiments was conducted with column-purified myosin, 
MyBP-C, and 14-kD peptide. For these latter experiments, 
myosin filaments (1.5 #M) in the 0.1 M KCl-imidazole-DTT 
binding buffer were incubated with MyBP-C (1.5 #M) and 
varying concentrations of 14-kD peptide (0-20 #M) for 15 
rain on ice, and then pelletted in the airfuge. Pellets and su- 
pernatants  were displayed by SDS-PAGE and stained with 
Coomassie blue. Again, no release of MyBP-C into the su- 
pernatant fractions was observed at any of these concentra- 
tions of the 14-kD peptide. 
Discussion 
We  have completed  the  sequence  of the fast  isoform of 
chicken skeletal muscle MyBP-C and used this sequence to 
map the position of four ot-chymotryptic fragments within 
the primary sequence. Then, using a myosin filament-bind- 
ing assay, we established that only the 14-kD fragment, lo- 
cated in the COOH-terminal end of the molecule and com- 
prising a single Ig C2 repeat,  is capable of binding myosin 
with high affinity, ,xO.5 #M. This result was confirmed using 
a recombinant 14-kD peptide produced in E. coll. This is the 
first direct demonstration of  a functional role for these motifs 
in a myosin-associated protein. These data do not exclude the 
possibilities that secondary binding sites may exist in the in- 
tact molecule, or that these may contribute to the complex 
binding interactions  with myosin filaments (Davis, 1988). 
The failure to release  MyBP-C from reconstituted  crude 
or pure myosin filaments with recombinant  14-kD peptide, 
even at 15-fold excess of the recombinant peptide, suggests 
that the interactions of MyBP-C with myosin filaments are 
complex.  This  is not unexpected:  immunolocalizations  of 
MyBP-C show that only a fraction (from 45-50%, depend- 
ing on the muscle fiber type) of the 43-nm axial repeats in 
the C zone of the A band contain MyBP-C (Dennis et al., 
1984). It has also been shown that a single sarcomere and 
single 43-nm  repeat  can contain  more than one MyBP-C 
isoform (Reinach et al.,  1983). Furthermore,  the localiza- 
tion of a single isoform may differ in different fiber types 
(Reinach et al., 1983). These results indicate that that the in- 
teraction of MyBP-C must differ along the filament. This no- 
tion is supported by Davis's experiments (1987) demonstrat- 
ing  four separate  classes  of C  protein:  myosin  filament 
binding sites which differ in affinity.  Those experiments were 
interpreted as implying a role of MyBP-C in myosin poly- 
merization and filament length regulation. Finally, MyBP-C 
is known to bind to titin (Ffirst et al., 1992) and interactions 
may exist with other thick filament-associated proteins, e.g., 
MyBP-H. Thus, it is unlikely to expect that the 14 kD: myo- 
sin interaction can explain all of the associative properties 
between MyBP-C and thick filaments. 
The production of a recombinant form of  this Ig C2 repeat 
in E. coli should allow the mapping of the myosin binding 
surface in this domain and the subsequent identification of 
the Ig C2 binding site in the myosin rod. 
The presence of both Ig C2 and Fn type IN repeats in pro- 
tein sequences was first observed in cell surface molecules 
involved in cell-cell and cell-substrate  adhesive interactions 
(Cunningham et al., 1987; Williams and Barclay, 1988) but 
was soon demonstrated in growth factor receptors  (Yarden 
and Ullrich,  1988), and proteins involved in viral binding 
and parasitic uptake (Ockenhouse et al.,  1992). In each of 
these molecules, the repeats have  been limited to extracellu- 
lax compartments. Over the past two years, eDNA cloning 
and primary sequence comparisons have shown that an in- 
creasing number of  intracellular, myosin-associated proteins 
in both vertebrates and invertebrates exhibit a similar repeat 
structure. These include: twitchin in C. elegans (Benian et 
al., 1989), chicken fast type MyBP-C (Einheber and Fisch- 
man,  1990), chicken  MyBP-H  (Vaughan et al.,  1993a), 
chicken M protein (Noguchi et al., 1992), mouse skelemin 
(Price et al., 1991), rabbit titin (Labeit et al.,  1990), Dro- 
sophila projectin (Ayme-Southgate et al., 1991; Fyrberg et 
al., 1992), human fast and slow type MyBP-C (Ffirst et al., 
1992), human MyBP-H (Vaughan  et al., 1993b), and smooth 
muscle myosin light chain kinase (MLCK) of chicken and 
bovine (Olson et al., 1990; Kobayashi et al., 1992) sources. 
Although most members of  this protein family bind myosin, 
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amino acid sequences of the 
COOH-terminal  14-kD sec- 
tion of the MyBP family and 
their comparison with the telo- 
kin (t) sequence./3 regions of 
/3 strand structure present in 
the telokin structure (Holden 
et  al.,  1992); (a)  residues 
10314132  of  chicken  fast 
muscle MyBP-C; (b) residues 
9594060 of human fast mus- 
cle  MyBP-C (Weber et  al., 
1993); (c) residues 437-539 of chicken fast muscle MyBP-H (Vaughan et al.,  1993a); (d) residues 374-476 of human fast muscle MyBP-H 
(Vaughan et al., 1993b); (e) residues 1036-1138  of  human slow muscle MyBP-C (Fiirst et al., 1992); (f) crosses (+) indicate the hydrophobic 
residues present in the chicken MyBP-C; (g) indicate the consensus sequence for all Ig C2 repeats present in MyBP-C, MyBP-H, twitchin, 
smooth muscle MLCK, twitchin, and projectin. Amino acid residues conserved on these five potential myosin-binding C2 motifs but not 
present in most C2 motifs are boxed. These highly conserved residues might be involved in myosin binding. 
no consensus myosin-binding motif has been identified, nor 
have the Fn or Ig motifs been shown previously to participate 
in the myosin-binding reactions. 
To  identify  such  a  motif we  decided  to  compare  the 
COOH-terminal  Ig  repeats  of the  MyBP-C and  MyBP-H 
family, since this is aconserved region of these proteins and 
is now known to contain the myosin-binding site in at least 
one member of the family, chicken fast type MyBP-C. To 
date, most sequence comparisons of the myosin-associated 
proteins have been extended to include all C2 motifs in the 
molecule (Benian et al.,  1989; Olson et al., 1990; Einheber 
et al.,  1990;  Vaughan et ai.,  1993a,b;  Price et al.,  1991; 
Labeit et al., 1991; Ffirst et al., 1992; Ayme-Southgate et al., 
1991;  Noguchi et ai.,  1992;  Kobayashi et al.,  1992).  As 
such, the comparisons have identified those amino acids con- 
served within all of these C2 motifs but have not identified 
residues which are potentially involved in myosin binding. 
To do so,  we have now restricted this  comparison to the 
COOH-terminal motifs of chicken fast type MyBP-C (Einhe- 
ber and Fischman, 1990), human fast and slow type MyBP-C 
(Ffirst et al.,  1992; Weber, E  E., unpublished results) and 
chicken  and  human  fast  type  MyBP-H  (Vaughan  et  al., 
1993a,b).  In  Fig.  6,  we have aligned the amino  acid  se- 
quences of the COOH-terminal regions of these proteins. 
Secondary structure predictions with the Chou-Fasman al- 
gorithm (Chou and Fasman,  1978), and direct analogy with 
the C2 motif  present in telokin, in which the crystal structure 
has been established (Holden et al.,  1992), have been used 
to  determine the  tentative positions  of seven potential  /3 
strands which constitute the B sheets characteristic of immu- 
noglobulins (Williams,  1987).  Surprisingly, more than 60 
out of 100 amino acids are conserved within these COOH- 
terminal repeats of the MyBPs, irrespective of their species 
or fiber type muscle origin. A similar comparison using all 
intracellular C2 motifs shows a  much lower degree of se- 
quence conservation, 39% (Weber et al., 1993). Of these 60 
residues we excluded those amino acids which are shared by 
all Ig C2 motifs and are considered determinants of the C2 
"signature" (see Fig. 6). The remaining 42 amino acids are 
conserved only in the C2 motifs believed to bind myosin 
(Fig.  6).  Those residues are organized in clusters along/~ 
strands  E,  F,  and  G,  and  in the  loop regions between /~ 
strands C and D (Fig. 6). In/~ strands A and C, we also found 
a  small  consensus  region.  When the position of the con- 
served side chains are mapped on the telokin structure, we 
find that some of these residues form two elongated patches 
on opposite sides of the telokin/3 barrel. A search of other 
Ig C2 motifs present in MLCK, twitchin and projectin with 
the amino acid clusters characteristic of the COOH-terminal 
domain did not reveal any homologies. This analysis sug- 
gests that MyBP-C and MyBP-H share a similar C2 immuno- 
globulin motif  in the COOH-terminus of  the molecule which 
evolved into a myosin binding site. In support of this notion, 
unpublished data from our laboratory indicate that MyBP-H 
and cardiac MyBP-C contain comparably sized proteolytic 
fragments which bind to myosin filaments (Alyonycheva, T., 
T. Mikawa, and D. A. Fischman.  1993). Furthermore, this 
C2 motif is likely to have a similar three-dimensional struc- 
ture to that of telokin. The production of recombinant 14-kD 
fragment in E.  coli should allow us to determine the struc- 
ture of this fragment and map the interface between the myo- 
sin rod and MyBP-C. 
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